Skip to Content

T. Rowe Price Integrated US Sm Gr Eq PRDSX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 46.49  /  +1.51 %
  • Total Assets 8.6 Bil
  • Adj. Expense Ratio
    0.800%
  • Expense Ratio 0.800%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield
  • Turnover 37%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis PRDSX

Will PRDSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

New era, but still an attractive quantitative option.

Senior Analyst Jack Shannon

Jack Shannon

Senior Analyst

Summary

Change is coming to T. Rowe Price Integrated US Small-Cap Growth Equity’s management team, but its consistent, quantitative-based approach still makes it an attractive option for investors.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PRDSX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 10.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Tenet Healthcare Corp

1.12 93.0 Mil
Healthcare

Weatherford International PLC Ordinary Shares - New

1.12 92.9 Mil
Energy

Wingstop Inc

1.07 88.3 Mil
Consumer Cyclical

Curtiss-Wright Corp

1.04 85.8 Mil
Industrials

Murphy USA Inc

1.00 83.0 Mil
Consumer Cyclical

FTAI Aviation Ltd

0.97 80.1 Mil
Industrials

Fabrinet

0.96 79.7 Mil
Technology

Insmed Inc

0.96 79.6 Mil
Healthcare

Onto Innovation Inc

0.95 78.5 Mil
Technology

Ensign Group Inc

0.93 77.0 Mil
Healthcare